Skip to main content
. 2019 Dec;371(3):652–662. doi: 10.1124/jpet.119.262188

TABLE 1.

IC50 values for PTP4A3 inhibitors

The in vitro IC50 values for the iminopyridinediones were determined with recombinant human protein using the artificial substrate DiFMUP, an automated liquid handling platform, and 25-minute incubation. N = 3 independent experiments unless otherwise marked.

Compound Mean (nM) ± S.E.M.
PTP4A1 PTP4A2 PTP4A3 PTP4A3 C49S PTP4A3 K144I PTP4A3 A106V PTP4A3 A111S CDC25B DUSP3
JMS-053 29.1 ± 2.7 48.0 ± 14.5 34.7 ± 2.5a 156.5 ± 20.1b 42.7 ± 8.0 26.3 ± 2.5 104.4 ± 7.7b,c 92.6 ± 10.2 207.6 ± 46.3
EJR-866-81 49.0 ± 5.0 112.9 ±10.0b 36.1 ± 1.4 390.0 ± 72.5b 59.1 ± 5.9 54.5 ± 2.4 61.0 ± 2.8b,c 65.5 ± 16.6 240.8 ± 30.9
EJR-866-75 43.2 ± 8.5 73.9 ± 10.0 98.2 ± 2.5d 229.7 ±54.6b 68.5 ± 1.0 57.5 ± 18.6 172.0 ± 46.0b,c,d 122.6 ± 22.6 521.0 ± 128.4
NRT-870-59e 133.2 ± 31.7a 264.4 ± 37.4a,b 86.0 ± 12.6a 332.2 ± 52.5b 180.2 ± 64.5e 57.7 ± 18.6 >1000c >1000 411.8 ± 75.3
JMS-038 >1000 >1000 >1000 ND >1000 ND ND ND >1000

ND, not determined.

a

N = 8.

b

P < 0.05 compared with PTP4A3.

c

N = 2.

d

N = 6.

e

N = 5.